Short Ragweed Allergy Shots: America's Best-Validated SCIT
Short ragweed allergy shots (SCIT) reduce nasal symptom scores by approximately 85% after two ragweed seasons per Creticos 2006 NEJM — the strongest single-allergen efficacy signal in modern US immunotherapy. FDA-standardized Ambrosia artemisiifolia extract dosed to 6–24 µg Amb a 1 per maintenance injection sets the gold standard. Roughly 30% of ragweed-sensitized adults also experience ragweed-melon-banana syndrome, making pre-treatment food history essential.
Short Ragweed Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to short ragweed — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of short ragweed allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of short ragweed immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of short ragweed extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for short ragweed allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing short ragweed extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription short ragweed immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat short ragweed allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Short Ragweed?
The biology, taxonomy, and clinical fingerprint of Short Ragweed — the foundation of how SCIT targets it.
Ambrosia artemisiifolia in flower; a single plant produces up to ~1 billion pollen grains per season and pollen travels 300–400 miles by wind.
- Scientific name
- Ambrosia artemisiifolia
- Family
- AsteraceaeSunflower family
- Type
- Annual weed pollen
- Native to
- North America; now present on all continents except Antarctica
- Allergen proteins
- Amb a 1 (major) — pectate lyase, >90–95% sensitizationAmb a 4 — defensin-like (Art v 1 homolog, mugwort cross-reactivity)Amb a 6 — nsLTP (clinically relevant, melon cross-reactivity)Amb a 8 — profilin (ragweed-melon-banana syndrome mediator)Amb a 11 — cysteine protease (~65% sensitization, asthma risk)Amb a 12 — enolase (~37% sensitization, characterized 2023)
- Particle size
- 16–27 µm
- Avoidance difficulty
- Nearly impossible
How Short Ragweed Allergy Presents
Symptoms by body system — useful for distinguishing Short Ragweed sensitivity from overlapping allergies and infections.
Respiratory
- Profuse watery rhinorrhea (runny nose) peaking mid-August to mid-September
- Nasal congestion and post-nasal drip
- Sneezing in prolonged episodes during high-count mornings
- Ragweed-triggered asthma exacerbations (wheezing, chest tightness)
- Sinusitis and eustachian tube dysfunction from sustained inflammation
Ocular
- Intense itching and redness of the conjunctiva
- Bilateral tearing and photophobia during peak counts
- Eyelid swelling, especially in the morning after outdoor exposure
- Allergic shiners (under-eye darkening from venous congestion)
Skin
- Contact dermatitis after direct plant contact (weed pulling without gloves)
- Urticaria (hives) during peak season in highly sensitized individuals
- Perioral itching or mild lip tingling after eating melon, banana, or cucumber (oral allergy syndrome)
- Eczema flares coinciding with ragweed season in atopic patients
Systemic
- Fatigue and cognitive fog ('brain fog') from histamine load and disrupted sleep
- Irritability and reduced quality of life across the entire 10–12 week ragweed season
- Oral allergy syndrome: itching of lips, mouth, and throat after consuming cantaloupe, honeydew, watermelon, banana, cucumber, or zucchini
- Chamomile tea or echinacea supplement reactions (Amb a 1-family cross-reactivity) — anaphylaxis has been reported
Ragweed is one of the clearest SCIT indications we have. Creticos 2006 NEJM reset expectations for what a single-allergen shot program can achieve. I tell patients: start build-up in January or February so you reach maintenance dose before August. And I always ask about cantaloupe and chamomile before we begin — those cross-reactions matter for safety on day one.
When & Where Short Ragweed Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Peak: mid-August through mid-September; season extends July–November in southern states· ~10–14 weeks of intense exposure in eastern US; climate change has added ~20 days to the season since 1990 (Anderegg 2021 PNAS)
US Exposure Map
23 high-intensity statesWhat Short Ragweed Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Short ragweed (Amb a 1) cross-reacts with other Ambrosia species through near-identical pectate-lyase epitopes, with mugwort (Artemisia) via Amb a 4 / Art v 6 homology, and with multiple foods through profilin (Amb a 8) — making ragweed one of the most network-connected pollen allergens in the US.
Amb t 5 shares >90–95% sequence identity with Amb a 1 isoallergens; short-ragweed extract delivers near-complete coverage
Amb p 5 is the A. psilostachya Group 1 ortholog; Ambrosia genus cross-reactivity is near-total
Amb a 4 and Art v 1 share ~69% sequence identity; co-sensitization is common in late-summer Asteraceae exposure
Amb a 8 (profilin) mediates itching and tingling; symptoms worsen during ragweed season
Cucurbitaceae family homology via profilin Amb a 8
Profilin cross-reactivity; also Amb a 6 nsLTP may contribute to more systemic reactions
Asteraceae family homology; anaphylaxis cases documented — warn patients before starting SCIT
Iva spp., same Heliantheae tribe; partial pollen cross-reactivity
Ragweed-Melon-Banana Syndrome
Approximately 30% of ragweed-sensitized adults experience oral allergy syndrome with cucurbit and Musaceae foods, mediated primarily by Amb a 8 (profilin) and secondarily by Amb a 6 (nsLTP). Symptoms are typically mild mouth tingling but can escalate — and chamomile tea specifically has caused anaphylaxis in Asteraceae-sensitized patients.
Is SCIT Right for Your Short Ragweed Allergy?
Answer five questions to see how strongly your symptom profile and lifestyle match the patients who benefit most from short-ragweed SCIT.
How severe are your ragweed season symptoms (August–October)?
The Short Ragweed SCIT Protocol
Short ragweed SCIT uses the only FDA-standardized weed extract in the US — Ambrosia artemisiifolia labeled in Amb a 1 µg/mL — with a target maintenance dose of 6–24 µg Amb a 1 per injection, consistent with the Creticos 2006 NEJM dosing that produced ~85% symptom reduction.
Your allergist progressively increases the Ambrosia artemisiifolia extract concentration from the most dilute starting vial toward the maintenance target dose. With Curex, your first dose and every dose increase are supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand and a brief self-observation afterward. Many allergists schedule the final build-up injections for early summer so the patient reaches maintenance before the August ragweed onset. Dose adjustments are made if you experience large local reactions.
Once the target dose (commonly 6–24 µg Amb a 1 per injection) is reached, injections shift to monthly. Your allergist may reduce the maintenance dose during the August–October peak ragweed window to minimize systemic reaction risk, then return to the full dose after first frost. Clinical benefit — measured as significantly reduced symptom scores — typically accumulates over the first two full ragweed seasons.
Most patients who complete 3–5 years of ragweed SCIT experience lasting immune tolerance that persists for years after stopping injections. The decision to stop is individualized: patients with confirmed Amb a 1 sensitization who had severe pre-treatment symptoms often extend the course. Sustained remission has been demonstrated in SCIT for seasonal pollen allergens in long-term follow-up studies.
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Short Ragweed SCIT
Short ragweed SCIT has the strongest single-allergen efficacy evidence of any US weed pollen immunotherapy, anchored by a landmark randomized double-blind placebo-controlled trial published in the New England Journal of Medicine.
- Nasal symptom score reduction85%
- Medication use reduction80%
- Symptom-medication score reduction (Phase III)65%
- Pooled symptom score improvement (meta-analysis)73%
- Ragwitek SLIT TCS reduction (comparator)27%
Short ragweed SCIT's ~85% symptom reduction per Creticos 2006 NEJM is the benchmark against which all other weed pollen immunotherapy options are measured. The Cochrane review (Calderon 2007) confirmed a number-needed-to-treat of approximately 3 for seasonal allergic rhinitis immunotherapy — meaning roughly one in three patients achieves meaningful improvement above placebo.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Short Ragweed SCIT Side Effects
Short ragweed SCIT side effects follow the standard SCIT safety profile, with local injection-site reactions being common and manageable, and serious systemic reactions being rare. With Curex's at-home program, your first dose and every dose change are supervised live over Zoom by the prescribing allergist, and a prescribed epinephrine auto-injector is confirmed on hand before you begin.
Local reactions
4 documentedSystemic reactions
4 documentedTraditionally SCIT was given only in a clinic, but for eligible maintenance patients Curex makes safe at-home self-administration possible: a personalized serum sterile-compounded to USP <797> and lot-tested, a prescribed epinephrine auto-injector confirmed on hand before the first injection, and the first dose plus every dose change supervised live over Zoom by the prescribing allergist. The vast majority of systemic reactions occur within the first 30 minutes, so a brief post-injection self-observation is advised. Patients with uncontrolled asthma or peak-season ragweed exposure receive modified (lower) doses during August–October.
SCIT vs Alternatives for Short Ragweed
Ragweed-allergic patients have four main evidence-based options: SCIT (~85% symptom reduction at 3 years), FDA-approved Ragwitek SLIT tablet (~27% TCS reduction), avoidance measures (largely ineffective given pollen's 300-mile travel range), or daily antihistamines plus nasal corticosteroids (good short-term relief, no lasting immune modification).
| Criterion | At-Home SCIT (Curex)Best | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | ~85% symptom reduction (Creticos 2006 NEJM) | ~27% TCS reduction (Ragwitek/Nolte 2013 JACI) | Minimal — pollen travels 300–400 miles | Good short-term control; breakthrough symptoms common |
| 5-yr cost | $3,500–$12,000 over 5 yrs | $1,500–$5,000 over 3 yrs | Low (HEPA filters, masks) | $500–$3,000 over 5 yrs |
| Duration | 3–5 years | 3 years (tablets) or ongoing (drops) | Ongoing, season after season | Annual, indefinitely |
| Convenience | Self-administered weekly at home with Curex during build-up, then monthly maintenance — no clinic visits | Daily sublingual drops or tablets at home | HEPA indoor air filtration, indoor refuge during peak | Daily or as-needed pills/sprays |
| Safety | Rare anaphylaxis (onset within ~30 min); Curex confirms a prescribed epinephrine auto-injector on hand and supervises your first dose and every dose change live over Zoom | Local mouth irritation; anaphylaxis very rare | No clinical risk | Antihistamine sedation, nasal steroid local effects |
| Lasting effect | Years of remission post-completion | Moderate lasting effect; less data than SCIT | No immune modification; symptoms return every fall | No lasting effect; symptoms recur if stopped |
At-Home SCIT (Curex)Best
SLIT
Avoidance
Medications
SCIT delivers the most durable outcome for short-ragweed allergy — its ~85% symptom reduction benchmark and years of post-treatment remission remain unmatched. Curex delivers that same ragweed immunotherapy as a weekly shot you give yourself at home for $129/month — a personalized serum sterile-compounded to USP <797>, your first dose and every dose change supervised live over Zoom by the prescribing allergist, with a prescribed epinephrine auto-injector confirmed on hand. It removes the weekly clinic trips of traditional build-up for eligible patients.
What Short Ragweed SCIT Actually Costs
Most major US health insurers cover short-ragweed SCIT under standard allergy benefits when prescribed by a board-certified allergist; actual out-of-pocket cost varies with deductible, copay, and whether your allergist bills extract preparation separately. Curex offers an at-home alternative: a personalized ragweed immunotherapy delivered as a self-administered weekly shot for $129/month all-inclusive (serum, supplies, and care team, HSA/FSA eligible) — a predictable flat fee for patients with high-deductible plans or limited clinic access.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
Flat monthly subscription — includes consult, prescription, and at-home dosing for sublingual immunotherapy.
See if you qualifyStop guessing about your short ragweed allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Short Ragweed SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Most patients notice measurable symptom improvement during their first full ragweed season after reaching maintenance dose — typically 3–6 months after starting the build-up phase. Creticos 2006 NEJM documented statistically significant symptom-score reductions over two consecutive ragweed seasons in patients who reached the 24 µg Amb a 1 maintenance target. Partial improvement often appears in the first season; the full ~85% reduction benchmark reflects cumulative immune re-education. This is why allergists recommend starting the build-up phase in January or February: patients who reach maintenance before the August ragweed onset get benefit in year one. If you start in September, the first full season of benefit may not come until the following fall.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.